This project focuses on developing and evaluating automated methods for analyzing complex no-code automation workflows used in enterprise environments. Platforms such as Workfront Fusion and Make.com allow organizations to build powerful automations quickly, but as these workflows grow in size and importance they often become difficult to understand, maintain, and safely modify. Changes are frequently […]

In 2023, Innovotech acquired a 60% interest in NouLife Sciences Inc., a company that developed the intellectual property for the linking of two antioxidant molecules commonly used in skin care products – alpha lipoic acid and acetyl-L-carnitine – into one molecule. The linking of the two molecules has been indicated by NouLife to increase the […]

Elev8 is working with L2M to help launch there MSK therapeutic device for tissue regeneration and longevity in the sport, military, and aging tech space.

In collaboration with the Lab2Market Launch program, our goal is to transition our natural polymer-based wound dressing from the lab bench to commercial scale. Designed specifically for individuals with chronic wounds and fragile skin conditions, our hydrogel-based dressing aims to fill a critical gap in the market. Through the program, we seek to deepen our […]

Wonder Guard is an AI-powered catheter sensor system that is capable of detecting and predicting infection. We are developing an infection surveillance system using electrochemical DNA biosensors and AI-driven analytics to make assisted diagnoses. The device is a module add-on to existing hospital catheter systems that can continuously produce and analyze data to monitor UTIs, […]

Dans un contexte de transition énergétique, le Québec prévoit accroître sa production d’énergies renouvelables comme l’éolien et le solaire. Cependant, cette évolution ne peut reposer uniquement sur de nouveaux investissements massifs dans les infrastructures électriques. Les Non-Wire Alternatives (NWA) telles que la gestion de la demande, le stockage d’énergie, les microréseaux ou les plateformes numériques […]

Globally, there have been challenges in pulling together data, analyses, epidemiological insights, and unusual infection disease trends into comprehensive and regular reporting, that support pharmaceutical and life sciences organizations with timely intelligence for decision making. BlueDot has the knowledge and expertise to bring together these insights in a highly visual, easily understandable regular reporting format, […]

This project focuses on launching and evaluating the NewGen Smart-Cup platform in clinical settings. NewGen Smart-Cup enables rapid, digital urine testing to support early detection of conditions such as preeclampsia and gestational diabetes. Building on prior validation work, this phase will study how healthcare teams adopt and integrate the technology into existing prenatal care routines. […]

This project will help Oncolinc Therapeutics, a cancer therapeutics company, build a clear strategy for bringing a new type of cancer treatment to market. Oncolinc Therapeutics is developing therapies that target long non-coding RNAs (lncRNAs), which are molecules that help some tumours hide from the immune system and resist current immunotherapies. Oncolinc needs guidance on […]

ReFem Technologies is developing IUAide, a new medical device that makes intrauterine device (IUD) insertion safer, faster, and less painful. The current procedure uses outdated tools that cause discomfort and inefficiency for both patients and clinicians. IUAide combines gentle stabilization, local anesthesia, and real-time placement feedback into one easy-to-use device. Through this project, ReFem will […]

Non-small cell lung cancer is one of the leading causes of cancer-related deaths, mainly because relapses are often detected too late. This research project aims to validate an innovative method to monitor patients after treatment by detecting tiny traces of tumor DNA circulating in the blood. Using a highly sensitive genome sequencing approach, it will […]

This project will launch LigandQI, a next-generation Contract Research Organization (CRO) that empowers researchers in the pharmaceutical and biotechnology sectors with advanced molecular-interaction analysis. LigandQI applies state-of-the-art quantum chemistry and computational modeling to reveal, with exceptional precision, how drug candidates bind to their target proteins, enabling faster, more accurate lead optimization. Through the Lab2Market Launch […]